USFDA flags Hetero Labs’ Nakkapalli facility with six serious observations
Hetero Labs' Nakkapalli facility has come under scrutiny after the USFDA identified six major compliance issues, including the use of ...
Hetero Labs' Nakkapalli facility has come under scrutiny after the USFDA identified six major compliance issues, including the use of ...
Biocon Ltd. actions Attend volatile movements on Tuesday, October 7, after its entirely subsidiary belonging to provisional approval of the ...